Vanderslice; Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vanderslice; Peter.The latest application filed is for "novel compositions including a therapeutic antibodies and/or a checkpoint inhibitor and an integrin activating compound".

Company Profile

8.11.13

Vanderslice; Peter - Houston TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Integrin activator vaccine compositions Grant 11,311,619 - Woodside , et al. April 26, 2	2022-04-26
Targeting nanoparticles Grant 11,312,685 - Woodside , et al. April 26, 2	2022-04-26
Novel Compositions Including A Therapeutic Antibodies And/or A Checkpoint Inhibitor And An Integrin Activating Compound App 20220001009 - Woodside; Darren G. ; et al.	2022-01-06
Imaging Agents and Methods of Use App 20210393811 - Woodside; Darren ; et al.	2021-12-23
Targeting Nanoparticles App 20210188774 - Woodside; Darren ; et al.	2021-06-24
Novel Integrin Activator Vaccine Compositions App 20210023207 - Woodside; Darren G. ; et al.	2021-01-28
Methods of administering novel integrin activator vaccine compositions Grant 10,716,849 - Woodside , et al.	2020-07-21
Integrin activator checkpoint inhibitor compositions Grant 10,709,781 - Woodside , et al.	2020-07-14
Integrin activator vaccine compositions Grant 10,709,780 - Woodside , et al.	2020-07-14
Novel Integrin Activator Checkpoint Inhibitor Compositions App 20200054743 - Woodside; Darren G. ; et al.	2020-02-20
Novel Integrin Activator Vaccine Compositions App 20190351052 - Woodside; Darren G. ; et al.	2019-11-21
Methods Of Administering Novel Integrin Activator Vaccine Compositions App 20190343952 - Woodside; Darren G. ; et al.	2019-11-14
Compositions and methods for immunotherapies comprising small molecule integrin receptor-ligand agonist adjuvants Grant 10,342,866 - Woodside , et al. July 9, 2	2019-07-09
Agonists that enhance binding of integrin-expressing cells to integrin receptors Grant 10,287,264 - Biediger , et al.	2019-05-14
Methods Of Using Cyclooxygenase-prostacyclin Synthase Fusion Gene App 20170042985 - DIXON; Richard A.F. ; et al.	2017-02-16
Agonists That Enhance Binding Of Integrin-expressing Cells To Integrin Receptors App 20170044130 - BIEDIGER; Ronald J. ; et al.	2017-02-16
Agonists that enhance binding of integrin-expressing cells to integrin receptors Grant 9,512,109 - Biediger , et al. December 6, 2	2016-12-06
Novel compositions and methods for immunotherapies comprising small molecule integrin receptor-ligand agonist adjuvants App 20160339098 - Woodside; Darren G. ; et al.	2016-11-24
Agonists That Enhance Binding Of Integrin-expressing Cells To Integrin Receptors App 20130236434 - Biediger; Ronald J. ; et al.	2013-09-12
Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds App 20070060608 - Vanderslice; Peter ; et al.	2007-03-15
Process to inhibit binding of the integrin .alpha.4.beta.1 , to VCAM-1 fibronectin and cyclic peptides thereof Grant 6,713,604 - Kogan , et al. March 30, 2	2004-03-30
Process to inhibit binding of the integrin .alpha..sub.4 62 .sub.1 to VCAM-1 or fibronectin and linear peptides therefor Grant 5,510,332 - Kogan , et al. April 23, 1	1996-04-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.